tetano
Editor, Senior Moderator
Biosecur Bioterror. 2011 Mar 1. [Epub ahead of print]
Protecting the Public from H1N1 through Points of Dispensing (PODs).
Rinchiuso-Hasselmann A, McKay RL, Williams CA, Starr DT, Morgenthau BM, Zucker JR, Raphael M.
Anne Rinchiuso-Hasselmann, MPH, was, at the time this article was written, Mass Prophylaxis Planning Manager; Ryan L. McKay, MPA, is Preparedness Planner; Christopher A. Williams, MPA, is Evaluation Coordinator; David T. Starr, MIA, is Director, Countermeasures Response Unit; Beth Maldin Morgenthau, MPH, is Deputy Director; and Marisa Raphael, MPH, is Assistant Commissioner; all are at the New York City Department of Health and Mental Hygiene, Office of Emergency Preparedness and Response, New York, NY. Jane R. Zucker, MD, MSc, is Assistant Commissioner, New York City Department of Health and Mental Hygiene , Bureau of Immunization, New York, NY, and is with the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention.
Abstract
In fall 2009, the New York City Department of Health and Mental Hygiene (DOHMH) operated 58 points of dispensing (PODs) over 5 weekends to provide influenza A (H1N1) 2009 monovalent vaccination to New Yorkers. Up to 7 sites were opened each day across the 5 boroughs, with almost 50,000 New Yorkers being vaccinated. The policies and protocols used were based on those developed for New York City's POD Plan, the cornerstone of the city's mass prophylaxis planning. Before the H1N1 experience, NYC had not opened more than 5 PODs simultaneously and had only experienced the higher patient volume seen with the H1N1 PODs on 1 prior occasion. Therefore, DOHMH identified factors that contributed to the success of POD operations, as well as areas for improvement to inform future mass prophylaxis planning and response. Though this was a relatively small-scale, preplanned operation, during which a maximum of 7 PODs were operated on a given day, the findings have implications for larger-scale mass prophylaxis planning for emergencies.
PMID: 21361797 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/21361797
Protecting the Public from H1N1 through Points of Dispensing (PODs).
Rinchiuso-Hasselmann A, McKay RL, Williams CA, Starr DT, Morgenthau BM, Zucker JR, Raphael M.
Anne Rinchiuso-Hasselmann, MPH, was, at the time this article was written, Mass Prophylaxis Planning Manager; Ryan L. McKay, MPA, is Preparedness Planner; Christopher A. Williams, MPA, is Evaluation Coordinator; David T. Starr, MIA, is Director, Countermeasures Response Unit; Beth Maldin Morgenthau, MPH, is Deputy Director; and Marisa Raphael, MPH, is Assistant Commissioner; all are at the New York City Department of Health and Mental Hygiene, Office of Emergency Preparedness and Response, New York, NY. Jane R. Zucker, MD, MSc, is Assistant Commissioner, New York City Department of Health and Mental Hygiene , Bureau of Immunization, New York, NY, and is with the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention.
Abstract
In fall 2009, the New York City Department of Health and Mental Hygiene (DOHMH) operated 58 points of dispensing (PODs) over 5 weekends to provide influenza A (H1N1) 2009 monovalent vaccination to New Yorkers. Up to 7 sites were opened each day across the 5 boroughs, with almost 50,000 New Yorkers being vaccinated. The policies and protocols used were based on those developed for New York City's POD Plan, the cornerstone of the city's mass prophylaxis planning. Before the H1N1 experience, NYC had not opened more than 5 PODs simultaneously and had only experienced the higher patient volume seen with the H1N1 PODs on 1 prior occasion. Therefore, DOHMH identified factors that contributed to the success of POD operations, as well as areas for improvement to inform future mass prophylaxis planning and response. Though this was a relatively small-scale, preplanned operation, during which a maximum of 7 PODs were operated on a given day, the findings have implications for larger-scale mass prophylaxis planning for emergencies.
PMID: 21361797 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/21361797